Alan Trounson. Interview by Asher Mullard.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Works matching IS 14741776 AND DT 2012 AND VI 11 AND IP 7
Results: 27
1
2
Amgen builds secondary hyperparathyroidism pipeline.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 579, doi. 10.1038/nrd3791
- By:
- Publication type:
- Article
3
Metabolic disorders: Heart microRNA provides new route to metabolic control.
- Published in:
- 2012
- By:
- Publication type:
- journal article
4
Deal watch: Epizyme-Celgene deal signals interest in new class of epigenetic drugs.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 508, doi. 10.1038/nrd3772
- By:
- Publication type:
- Article
5
FDA advisory committee meeting outcomes.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 513, doi. 10.1038/nrd3747
- By:
- Publication type:
- Article
6
Regulatory watch: Crossing the regulatory finish line.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 509, doi. 10.1038/nrd3774
- Publication type:
- Article
7
Neurodevelopmental disorders: exploring the links between SHANK2 and autism.
- Published in:
- 2012
- By:
- Publication type:
- journal article
8
Anticancer TLR agonists on the ropes.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 503, doi. 10.1038/nrd3775
- By:
- Publication type:
- Article
9
Ageing: Telomerase gene therapy increases longevity.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 518, doi. 10.1038/nrd3795
- By:
- Publication type:
- Article
10
New horizons in pharmaceutical regulation.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 501, doi. 10.1038/nrd3787
- By:
- Publication type:
- Article
11
Alan Trounson.
- Published in:
- 2012
- Publication type:
- Interview
12
Busy panels recommend Pfizer's tofacitinib, Arena's lorcaserin and more.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 579, doi. 10.1038/nrd3778
- By:
- Publication type:
- Article
13
Neurodegenerative disorders: Alzheimer's toxic chain reaction.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 518, doi. 10.1038/nrd3797
- By:
- Publication type:
- Article
14
Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 560, doi. 10.1038/nrd3649
- By:
- Publication type:
- Article
15
Drug repurposing programmes get lift off.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 505, doi. 10.1038/nrd3776
- By:
- Publication type:
- Article
16
Antibody-enabled small-molecule drug discovery.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 519, doi. 10.1038/nrd3756
- By:
- Publication type:
- Article
17
Anticancer drugs: Reactivating p53.
- Published in:
- 2012
- By:
- Publication type:
- journal article
18
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 541, doi. 10.1038/nrd3745
- By:
- Publication type:
- Article
19
Market watch: Upcoming market catalysts in Q3 2012.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 508, doi. 10.1038/nrd3773
- By:
- Publication type:
- Article
20
Diabetes: A mechanism of metabolically driven pain.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 518, doi. 10.1038/nrd3798
- By:
- Publication type:
- Article
21
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 510, doi. 10.1038/nrd3785
- By:
- Publication type:
- Article
22
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 499, doi. 10.1038/nrd3786
- Publication type:
- Article
23
Anticancer drugs: Antipsychotic to anticancer agent?
- Published in:
- 2012
- By:
- Publication type:
- journal article
24
Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 527, doi. 10.1038/nrd3746
- By:
- Publication type:
- Article
25
Cancer: Of targets and anti-targets.
- Published in:
- 2012
- By:
- Publication type:
- journal article
26
Cardiovascular disorders: A new class of antithrombotic agents.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 518, doi. 10.1038/nrd3796
- By:
- Publication type:
- Article
27
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 507, doi. 10.1038/nrd3784
- Publication type:
- Article